{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:59:54Z","timestamp":1792789194365,"version":"4.5.0"},"reference-count":75,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82360161"],"award-info":[{"award-number":["82360161"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["81960155"],"award-info":[{"award-number":["81960155"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"award":["82360161"],"award-info":[{"award-number":["82360161"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["81960155"],"award-info":[{"award-number":["81960155"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Major Science and Technology Innovation Projects in the Health Sector of Gansu Province","award":["GSWSZD2025-07"],"award-info":[{"award-number":["GSWSZD2025-07"]}]},{"name":"joint Fund project of Gansu Province","award":["24JRRA918"],"award-info":[{"award-number":["24JRRA918"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common metabolic disorder that affects the endocrine and digestive systems. It often leads to multi-system metabolic abnormalities, including disturbances in blood glucose and lipid levels. MASLD ranges from normal liver to steatosis, followed by fibrosis and cirrhosis, eventually leading to hepatocellular carcinoma. This disease can exacerbate liver-related complications and promote the development of extrahepatic diseases in other systems, including the cardiovascular and renal systems. Melatonin, a regulator of neurotransmitters, hormones, and biological responses, modulates oxidative stress, buffers free radicals, influences mitochondrial function, and regulates energy. Therefore, melatonin may serve as a novel adjunctive therapeutic agent for delaying or inhibiting the development of MASLD. We summarize the recent research progress on the effects of melatonin on MASLD and related molecular mechanisms, and identify new ideas and targets for MASLD treatment.<\/jats:p>","DOI":"10.3390\/biom16091357","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:01:38Z","timestamp":1789981298000},"page":"1357","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Melatonin: Roles and Molecular Mechanisms in Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.3390","volume":"16","author":[{"given":"Binjing","family":"Pan","sequence":"first","affiliation":[{"name":"The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lv","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Guo","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfang","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China"},{"name":"Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou 730000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s13679-025-00637-9","article-title":"Metabolically Healthy Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the Controversies in Disease Development and Progression","volume":"14","author":"Koliaki","year":"2025","journal-title":"Curr. Obes. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2500099","DOI":"10.1080\/19490976.2025.2500099","article-title":"Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease","volume":"17","author":"Wu","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","article-title":"NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann. Hepatol."},{"key":"ref_4","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2024). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol., 81, 492\u2013542."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00592-025-02479-2","article-title":"The interactions between melatonin and the renin-angiotensin system (RAS) in vascular attenuation in diabetic and non-diabetic conditions","volume":"62","author":"Mahmood","year":"2025","journal-title":"Acta Diabetol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wolda\u0144ska-Oko\u0144ska, M., and Koszela, K. (2024). The Physiological Impact of Melatonin, Its Effect on the Course of Diseases and Their Therapy and the Effect of Magnetic Fields on Melatonin Secretion-Potential Common Pathways of Influence. Biomolecules, 14.","DOI":"10.3390\/biom14080929"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8876792","DOI":"10.1155\/2021\/8876792","article-title":"Melatonin to Rescue the Aged Heart: Antiarrhythmic and Antioxidant Benefits","volume":"2021","author":"Diez","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ortiz-Plac\u00edn, C., Salido, G.M., and Gonz\u00e1lez, A. (2025). Melatonin Interplay in Physiology and Disease-The Fountain of Eternal Youth Revisited. Biomolecules, 15.","DOI":"10.3390\/biom15050682"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sieminski, M., Reimus, M., Ka\u0142as, M., and St\u0119pniewska, E. (2024). Antioxidant and Anti-Inflammatory Properties of Melatonin in Secondary Traumatic Brain Injury. Antioxidants, 14.","DOI":"10.3390\/antiox14010025"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11033-025-10306-8","article-title":"Cellular signalling of melatonin and its role in metabolic disorders","volume":"52","author":"Tripathy","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1152\/physiol.00011.2014","article-title":"Melatonin: Exceeding expectations","volume":"29","author":"Reiter","year":"2014","journal-title":"Physiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"108890","DOI":"10.1016\/j.intimp.2022.108890","article-title":"Modulation of the immune system by melatonin; implications for cancer therapy","volume":"108","author":"Moslehi","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Won, E., Na, K.S., and Kim, Y.K. (2021). Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010305"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0192-0561(93)90060-C","article-title":"Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation","volume":"15","author":"Pioli","year":"1993","journal-title":"Int. J. Immunopharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"de Lux\u00e1n-Delgado, B., Potes, Y., Rubio-Gonz\u00e1lez, A., Solano, J.J., Boga, J.A., Antu\u00f1a, E., Cach\u00e1n-Vega, C., Bermejo-Millo, J.C., Men\u00e9ndez-Coto, N., and Garc\u00eda-Gonz\u00e1lez, C. (2024). Melatonin Alleviates Liver Mitochondrial Dysfunction in Leptin-Deficient Mice. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168677"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e70285","DOI":"10.1111\/jcmm.70285","article-title":"Melatonin Reduces Mito-Inflammation in Ischaemic Hippocampal HT22 Cells and Modulates the cGAS-STING Cytosolic DNA Sensing Pathway and FGF21 Release","volume":"28","author":"Carloni","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s10495-025-02096-y","article-title":"Melatonin attenuates inflammatory bone loss by alleviating mitophagy and lactate production","volume":"30","author":"Lin","year":"2025","journal-title":"Apoptosis Int. J. Program. Cell Death"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Portincasa, P., Khalil, M., Mahdi, L., Perniola, V., Idone, V., Graziani, A., Baffy, G., and Di Ciaula, A. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115640"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.37765\/ajmc.2024.89635","article-title":"Management strategies for metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"30","author":"Alkhouri","year":"2024","journal-title":"Am. J. Manag. Care"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Li, X., Chen, W., Jia, Z., Xiao, Y., Shi, A., and Ma, X. (2025). Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094256"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Costache, D.O., Blejan, H., Cojocaru, D.L., Ioni\u021b\u0103, G.A., Poenaru, M., Constantin, M.M., Costache, A.C., C\u0103runtu, C., Balaban, D.V., and Costache, R.S. (2024). Intersecting Pathways: Nonalcoholic Fatty Liver Disease and Psoriasis Duet-A Comprehensive Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052660"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Park, H.J., Choi, J., Kim, H., Yang, D.Y., An, T.H., Lee, E.W., Han, B.S., Lee, S.C., Kim, W.K., and Bae, K.H. (2023). Cellular heterogeneity and plasticity during NAFLD progression. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1221669"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Fa, P., Ke, B.G., Dupre, A., Tsung, A., and Zhang, H. (2023). The implication of neutrophil extracellular traps in nonalcoholic fatty liver disease. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1292679"},{"key":"ref_24","first-page":"452","article-title":"Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"11","author":"Liu","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.34172\/mejdd.2022.270","article-title":"Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology","volume":"14","author":"Akter","year":"2022","journal-title":"Middle East J. Dig. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.21037\/jtd-cus-2020-012","article-title":"Sleep disorder in patients with chronic liver disease: A narrative review","volume":"12","author":"Shah","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/17474124.2019.1684899","article-title":"From circadian clocks to non-alcoholic fatty liver disease","volume":"13","author":"Ji","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e12961","DOI":"10.1111\/jpi.12961","article-title":"Melatonin in energy control: Circadian time-giver and homeostatic monitor","volume":"76","author":"Challet","year":"2024","journal-title":"J. Pineal Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kvedariene, V., Vaskovic, M., and Semyte, J.B. (2025). Role of Oxidative Stress and Antioxidants in the Course of Atopic Dermatitis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094210"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1007\/s12035-024-03915-0","article-title":"Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management","volume":"61","author":"Megha","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.lfs.2004.03.003","article-title":"Melatonin and mitochondrial function","volume":"75","author":"Leon","year":"2004","journal-title":"Life Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"BSR20230128","DOI":"10.1042\/BSR20230128","article-title":"Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model","volume":"43","author":"Saha","year":"2023","journal-title":"Biosci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.18388\/abp.2003_3637","article-title":"Melatonin as an antioxidant: Biochemical mechanisms and pathophysiological implications in humans","volume":"50","author":"Reiter","year":"2003","journal-title":"Acta Biochim. Pol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.3748\/wjg.v28.i39.5691","article-title":"Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations","volume":"28","author":"Theofilis","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Du, W., and Wang, L. (2022). The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.936196"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.lfs.2005.04.013","article-title":"Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stress","volume":"77","author":"Wang","year":"2005","journal-title":"Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20587384211036819","DOI":"10.1177\/20587384211036819","article-title":"Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db\/db mice","volume":"35","author":"Yu","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Aranda-Mart\u00ednez, P., Fern\u00e1ndez-Mart\u00ednez, J., Ram\u00edrez-Casas, Y., Guerra-Librero, A., Rodr\u00edguez-Santana, C., Escames, G., and Acu\u00f1a-Castroviejo, D. (2022). The Zebrafish, an Outstanding Model for Biomedical Research in the Field of Melatonin and Human Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137438"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Joseph, T.T., Schuch, V., Hossack, D.J., Chakraborty, R., and Johnson, E.L. (2024). Melatonin: The placental antioxidant and anti-inflammatory. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1339304"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4927403","DOI":"10.1155\/2020\/4927403","article-title":"Melatonin Alleviates Glucose and Lipid Metabolism Disorders in Guinea Pigs Caused by Different Artificial Light Rhythms","volume":"2020","author":"Liu","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e31383","DOI":"10.1002\/jcp.31383","article-title":"Melatonin regulates endoplasmic reticulum stress in diverse pathophysiological contexts: A comprehensive mechanistic review","volume":"239","author":"Seiva","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1357-2725(01)00138-8","article-title":"Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria","volume":"34","author":"Escames","year":"2002","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lei, X., Xu, Z., Huang, L., Huang, Y., Tu, S., Xu, L., and Liu, D. (2024). The potential influence of melatonin on mitochondrial quality control: A review. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1332567"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"122993","DOI":"10.1016\/j.lfs.2024.122993","article-title":"Role of melatonin in mitigation of insulin resistance and ensuing diabetic cardiomyopathy","volume":"355","author":"Nath","year":"2024","journal-title":"Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"103073","DOI":"10.1016\/j.dsx.2024.103073","article-title":"Exploring effects of melatonin supplementation on insulin resistance: An updated systematic review of animal and human studies","volume":"18","author":"Fayazi","year":"2024","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2011.04.049","article-title":"Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease","volume":"662","author":"Zaitone","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40200-023-01293-3","article-title":"Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review","volume":"22","author":"Ziamanesh","year":"2023","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41522-024-00605-6","article-title":"Microbial melatonin metabolism in the human intestine as a therapeutic target for dysbiosis and rhythm disorders","volume":"10","author":"Zimmermann","year":"2024","journal-title":"npj Biofilms Microbiomes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e12399","DOI":"10.1111\/jpi.12399","article-title":"Melatonin prevents obesity through modulation of gut microbiota in mice","volume":"62","author":"Xu","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ghareghani, M., Reiter, R.J., Zibara, K., and Farhadi, N. (2018). Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02484"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Gao, J., Xu, K., Liu, H., Liu, G., Bai, M., Peng, C., Li, T., and Yin, Y. (2018). Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00013"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e70005","DOI":"10.1111\/jpi.70005","article-title":"Melatonin Ameliorates Cadmium-Induced Liver Fibrosis Via Modulating Gut Microbiota and Bile Acid Metabolism","volume":"76","author":"Liu","year":"2024","journal-title":"J. Pineal Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00018-022-04412-0","article-title":"Melatonin relieves hepatic lipid dysmetabolism caused by aging via modifying the secondary bile acid pattern of gut microbes","volume":"79","author":"Wei","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"151978","DOI":"10.1016\/j.bbrc.2025.151978","article-title":"Association between sleep disturbance and metabolic dysfunctions in adipose tissue: Insights into melatonin\u2019s role","volume":"770","author":"Ratwani","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"113975","DOI":"10.1016\/j.physbeh.2022.113975","article-title":"Melatonin protects against body weight gain induced by sleep deprivation in mice","volume":"257","author":"Hu","year":"2022","journal-title":"Physiol. Behav."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00011-020-01393-3","article-title":"Sleep deprivation aggravated lipopolysaccharide\/D-galactosamine-induced acute liver injury by suppressing melatonin production","volume":"69","author":"Liu","year":"2020","journal-title":"Inflamm. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00125-015-3769-3","article-title":"Circulating leptin in non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"59","author":"Polyzos","year":"2016","journal-title":"Diabetologia"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/zeb.2020.1910","article-title":"Effect of Melatonin on the Reduction of Hepatic Steatosis and Intestinal Leptin Expression in Zebrafish Exposed to Fructose","volume":"18","author":"Schneider","year":"2021","journal-title":"Zebrafish"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1007\/s00210-023-02784-z","article-title":"Assessment of melatonin\u2019s therapeutic effectiveness against hepatic steatosis induced by a high-carbohydrate high-fat diet in rats","volume":"397","author":"Dorranipour","year":"2024","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3803\/EnM.2023.1672","article-title":"Protective Effects of Melatonin in High-Fat Diet-Induced Hepatic Steatosis via Decreased Intestinal Lipid Absorption and Hepatic Cholesterol Synthesis","volume":"38","author":"Ku","year":"2023","journal-title":"Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"112753","DOI":"10.1016\/j.celrep.2023.112753","article-title":"Rebalancing liver-infiltrating CCR3+ and CD206+ monocytes improves diet-induced NAFLD","volume":"42","author":"Sun","year":"2023","journal-title":"Cell Rep."},{"key":"ref_62","first-page":"35","article-title":"Role of melatonin, glutamine and l-arginine in prevention of non-alcoholic fatty liver disease in rats","volume":"39","author":"Obydah","year":"2019","journal-title":"Bull. Egypt. Soc. Physiol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1007\/s10753-022-01667-4","article-title":"Melatonin Attenuates Inflammation, Oxidative Stress, and DNA Damage in Mice with Nonalcoholic Steatohepatitis Induced by a Methionine- and Choline-Deficient Diet","volume":"45","author":"Miguel","year":"2022","journal-title":"Inflammation"},{"key":"ref_64","first-page":"7315253","article-title":"Effect of Melatonin as an Antioxidant Drug to Reverse Hepatic Steatosis: Experimental Model","volume":"2020","author":"Pola","year":"2020","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"102835","DOI":"10.1016\/j.psj.2023.102835","article-title":"Melatonin alleviates cadmium-induced nonalcoholic fatty liver disease in ducks by alleviating autophagic flow arrest via PPAR-\u03b1 and reducing oxidative stress","volume":"102","author":"Sun","year":"2023","journal-title":"Poult. Sci."},{"key":"ref_66","first-page":"e220075","article-title":"Melatonin alleviates diet-induced steatohepatitis by targeting multiple cell types in the liver to suppress inflammation and fibrosis","volume":"70","author":"Xu","year":"2022","journal-title":"J. Mol. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/JIR.S343236","article-title":"Melatonin Suppresses NLRP3 Inflammasome Activation via TLR4\/NF-\u03baB and P2X7R Signaling in High-Fat Diet-Induced Murine NASH Model","volume":"15","author":"Saha","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12013-018-0859-0","article-title":"Melatonin Modulates lipid Metabolism in HepG2 Cells Cultured in High Concentrations of Oleic Acid: AMPK Pathway Activation may Play an Important Role","volume":"76","author":"Mi","year":"2018","journal-title":"Cell Biochem. Biophys."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Stacchiotti, A., Favero, G., Lavazza, A., Golic, I., Aleksic, M., Korac, A., Rodella, L.F., and Rezzani, R. (2016). Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob\/ob Mice Non-Alcoholic Fatty Liver Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148115"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12944-016-0370-9","article-title":"Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK\/P38 signaling in high-fat-diet-induced obese mice","volume":"15","author":"Sun","year":"2016","journal-title":"Lipids Health Dis."},{"key":"ref_71","first-page":"103","article-title":"Features of excretion of melatonin in urine in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease with manifestations of fibrosis and its relationship with certain metabolic and immunological indicators","volume":"274","author":"Zemlianitsyna","year":"2018","journal-title":"Georgian Med. News"},{"key":"ref_72","first-page":"75","article-title":"Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up","volume":"65","author":"Celinski","year":"2014","journal-title":"J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc."},{"key":"ref_73","first-page":"35","article-title":"The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: A pilot study","volume":"63","author":"Gonciarz","year":"2012","journal-title":"J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc."},{"key":"ref_74","first-page":"577","article-title":"The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis","volume":"61","author":"Celinski","year":"2010","journal-title":"J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.ctim.2020.102452","article-title":"The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: A randomized double blind clinical trial","volume":"52","author":"Bahrami","year":"2020","journal-title":"Complement. Ther. Med."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/9\/1357\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:27:06Z","timestamp":1790051226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/9\/1357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":75,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["biom16091357"],"URL":"https:\/\/doi.org\/10.3390\/biom16091357","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}